Anticancer efficacy of a novel propofol–linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma

Author： Khan Azmat Ali   Jabeen Mumtaz   Khan Aijaz Ahmed   Owais Mohammad  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.20, Iss.20, 2013-01, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic lethal interaction of combined CD26 and Bcl‐xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 9, 2015-09 ,pp. : 1023-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preparation, characterization and anticancer therapeutic efficacy of cisplatin-loaded niosomes

By Yang Hong  

Journal of Microencapsulation, Vol. 30, Iss. 3, 2013-05 ,pp. : 237-244

Informa Healthcare

Access to resources Recommend Favorite

Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro

By            

International Journal of Molecular Medicine, Vol. 31, Iss. 4, 2013-01 ,pp. : 967-974

Spandidos Publications

Access to resources Recommend Favorite

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 8, 2015-08 ,pp. : 906-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nanocapsules: a novel formulation technology for platinum-based anticancer drugs

By Hamelers Irene HL   de Kroon Anton IPM  

Future Lipidology, Vol. 2, Iss. 4, 2007-08 ,pp. : 445-453

Future Medicine

Access to resources Recommend Favorite